BIRC5 and acute leukemia: As bone marrow samples from other types' acute leukemia were also analyzed, the result indicated that survivin mRNA expression rate of de novo and relapse APLs were obviously lower (67% versus 91%, P = 0.03), more lower in remission patients (67% versus 36%, P = 0.03).